Product Information
CLONAZEPAM 2 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0378 per EA under NDC 72888015405. Its NADAC has been published 161 times since May 31, 2023.
Strength
2 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888015405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA075468On Market Since
4/14/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG TABLET has been published 161 times since May 31, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0378 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0316 (Nov 20, 2024) |
| 52-week high | $0.0436 |
| 52-week low | $0.0378 |
| Median price | $0.0413 |
| Average price | $0.0402 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 161 |
| Tracking since | May 31, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0378 per EA (NDC 72888015405), effective Jun 24, 2026.
How has the price of CLONAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 161 weekly CMS publications since May 31, 2023.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG TABLET?
Since May 31, 2023, the NADAC for CLONAZEPAM 2 MG TABLET has ranged from a low of $0.0316 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0413 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 2 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 2 MG TABLET?
CLONAZEPAM 2 MG TABLET (NDC 72888015405) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification